Sitaramesh Emani

ORCID: 0000-0003-0175-9281
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Cardiac Structural Anomalies and Repair
  • Transplantation: Methods and Outcomes
  • Heart Failure Treatment and Management
  • Renal Transplantation Outcomes and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrest and Resuscitation
  • Organ Transplantation Techniques and Outcomes
  • Obstructive Sleep Apnea Research
  • Cardiovascular Function and Risk Factors
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Neuroscience of respiration and sleep
  • Heart Rate Variability and Autonomic Control
  • Fuel Cells and Related Materials
  • Heart rate and cardiovascular health
  • Pulmonary Hypertension Research and Treatments
  • Organ and Tissue Transplantation Research
  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Congenital Heart Disease Studies
  • COVID-19 Clinical Research Studies
  • Sleep and Wakefulness Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Long-Term Effects of COVID-19

The Ohio State University Wexner Medical Center
2015-2025

The Ohio State University
2014-2024

Health Net
2024

Christ Hospital
2024

University of California, Riverside
2024

Allegheny General Hospital
2017

Virginia Commonwealth University
2017

University of Chicago
2017

Abbott (United States)
2017

Columbia University
2017

Isolated diastolic dysfunction is found in almost half of asymptomatic patients with well-controlled diabetes and may precede heart failure. However, mechanisms that underlie during are not well understood. We tested the hypothesis isolated associated impaired myocardial Ca(2+) handling type 1 diabetes. Streptozotocin-induced diabetic rats were compared age-matched placebo-treated rats. Global left ventricular performance systolic function preserved animals. Diabetes-induced was evident on...

10.1152/ajpregu.00059.2007 article EN AJP Regulatory Integrative and Comparative Physiology 2007-08-30

Gastrointestinal (GI) bleeding is one of the most common complications after continuous-flow left ventricular assist device implantation. More than third patients with incident bleed go on to develop recurrent GI bleeding. Octreotide, a somatostatin analog, proposed reduce risk in this population.This multicenter, retrospective analysis evaluated 51 who received secondary prophylaxis octreotide their index from 2009 2015. All had hospitalization for and discharge. Patient demographics,...

10.1161/circheartfailure.117.004500 article EN Circulation Heart Failure 2017-11-01

Heart rate (HR) affects heart failure outcomes, via uncertain mechanisms that may include left ventricular remodeling. However, in human myocardium, HR change has not been associated with a particular remodeling molecular phenotype. Patients nonischemic dilated cardiomyopathy (N=22) sinus rhythm and refractory to β-blockade for both lowering reverse were randomized 2:1 double-blind the HCN4 (hyperpolarization-activated cyclic nucleotide-gated potassium channel 4) inhibitor ivabradine or...

10.1161/circheartfailure.124.012484 article EN cc-by-nc-nd Circulation Heart Failure 2025-03-07

Although percutaneous, adenoviral-mediated intracoronary gene delivery to the heart has been demonstrated in some species, consistent and safe methodology is needed before clinical applicability possible. In this study, we examine effects of altering flow rate obtaining an adequate seal between catheter coronary lumen on successful cardiac myocardial injury both piglets adult rabbits. To study efficacy vivo transfer, utilized adenoviral vectors containing either β2-adrenergic receptor or...

10.1016/s1525-0016(03)00149-7 article EN cc-by-nc-nd Molecular Therapy 2003-06-02

To test the hypotheses that receipt of Medicaid or Medicare (versus private insurance self-pay) and low socioeconomic status (SES) leads to increased mortality lower chances transplantation among heart transplant (HTx) candidates with bridge left ventricular assist devices (BTT LVADs).Survival while awaiting HTx has improved use BTT LVADs. However, it is unknown whether benefits extend uniformly across patient groups based on status.Data from United Network Organ Sharing (UNOS) registry...

10.1111/ctr.12875 article EN Clinical Transplantation 2016-11-16

10.1016/j.jacbts.2022.02.015 article EN cc-by-nc-nd JACC Basic to Translational Science 2022-03-01
Coming Soon ...